The Trump administration's sudden cancellation of a $258 million HIV vaccine research program has ignited outrage among scientists and public health advocates, jeopardizing years of progress in HIV prevention and treatment as infection rates surge.
Today, the U.S. Supreme Court hears a pivotal case on Obamacare's preventive care mandate, with major implications for health coverage, including HIV prevention drugs like PrEP. Conservative employers argue the mandate is unconstitutional, raising fears about the future of essential health services.
A new study reveals that cuts in foreign aid by Western nations could lead to over 10 million new HIV infections and nearly 3 million deaths by the decade's end, particularly affecting vulnerable populations.
In a surprising turn, the Trump administration has terminated key funding for HIV programs aimed at adolescents, raising concerns over the future of HIV prevention efforts in the U.S.
A dramatic standoff erupted between President Trump’s administration and a congressionally chartered nonprofit, led by Elon Musk. As police were called in to evict staff, both sides face off in court over control and funding, revealing deep rifts in HIV prevention efforts and federal operations.
The Trump administration is reportedly discussing potential cuts to the CDC’s domestic HIV program, sparking concerns over the future of HIV prevention efforts across the U.S. Advocates warn about the implications for testing and outreach as the administration seeks to streamline federal spending.
Experts warn that dramatic US funding cuts could reverse decades of progress in HIV prevention and treatment, putting millions at risk and jeopardizing the goal of ending AIDS by 2030.
